Ecaterina Vasenina

Dr. Ecaterina Vasenina


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2023 in Sports
Verified
Journal Article
Open access
PDF file
EVEcaterina Vasenina
Ecaterina Vasenina
Jeffrey StoutJeffrey Stout
Jeffrey Stout
David H. FukudaDavid H. Fukuda
David H. Fukuda
(1) Background: There is a lack of literature that examines the impact of early vs. late sport specialization on quality of life after retirement from tennis. Thus, the purpose of this study was to examine the relationship between early specialization in the sport of tennis and health outcomes after retirement from collegiate/professional sport; (2) Methods: Participants were recruited through social media posts, newsletters, and contacts with tennis organizations. Basic demographic and injury information was collected from 157 former tennis players, along with the age of tennis specialization and two questionnaires: the Oslo Sports Trauma Research Center Questionnaire on Health Problems (OSTRC), and the CDC HRQOL-14 “Healthy Days Measure” Questionnaire (HRQOL); (3) Results: Significant differences (F1,117 = 5.160, p < 0.025) in the specialization age between the low (11.9 ± 4.5 y) and high (9.8 ± 4.1 y) OSTRC groups were found after covarying for the current age. No difference (F1,72 = 0.676, p < 0.414) was shown among the high (10.9 ± 4.4 y) and low (11.28 ± 4.6 y) HRQOL groups for the specialization age after covarying for the current age. A weak negative correlation was identified between the OSTRC score and specialization age (r = −0.233, p = 0.008), while no significant changes were shown between the specialization age and HRQOL score (r = −0.021, p = 0.857), or between the OSTRC and HRQOL scores (r = 0.146, p = 0.208); (4) Conclusions: Retired tennis players with low injury/illness severity scores specialized in tennis later than those with high injury/illness severity scores, while no differences in the specialization age were noted when the sample was separated into HRQOL groups.

3 June 2026 in Current Nutrition Reports
Verified
Journal Article
Open access
JKJennifer Kurtz
Jennifer Kurtz
KSK. Michelle Singleton
K. Michelle Singleton
EVEcaterina Vasenina
Ecaterina Vasenina
RJRalf Jäger
Ralf Jäger
DGDrew Gonzalez
Drew Gonzalez
JAJose Antonio
Jose Antonio
Purpose of Review: Aging is marked by progressive physiological decline driven by chronic inflammation, mitochondrial dysfunction, and impaired metabolic and musculoskeletal resilience. As the global population ages, dietary supplements have gained attention as potential tools to support healthy longevity. This review summarizes current evidence on nutritional compounds that target aging-related pathways, focusing on interventions that influence mitochondrial health, cognitive performance, immune function, metabolic regulation, and maintenance of muscle mass in older adults. Thirty-two human studies were identified through PubMed, Scopus, and Web of Science. Recent Findings: Evidence indicates that several targeted nutrients, including protein, probiotics, antioxidants, and emerging mitochondrial-support compounds, may contribute to healthy aging. Protein and collagen supplementation, particularly when paired with resistance training, consistently improve muscle mass and physical function. Antioxidants, glycine, N-acetylcysteine, and NAD⁺ precursors show potential benefits for mitochondrial efficiency, cellular stress responses, and cognitive performance; however, findings vary across populations and dosing strategies. Heterogeneity in study designs, supplement formulations, and biomarker endpoints underscores the need for individualized and context-specific application. Summary: A personalized, evidence-informed supplementation strategy integrated with exercise and balanced nutrition may help optimize physiological function in aging adults. Future research should refine dosing protocols, evaluate synergistic nutrient combinations, and clarify the roles of antioxidants and mitochondrial-targeted compounds across diverse older populations.

9 July 2026 in Nutrients
Verified
Journal Article
Open access
PDF file
RJRalf Jäger
Ralf Jäger
HLHendrik Luesch
Hendrik Luesch
MPMartin Purpura
Martin Purpura
AGAshok Godavarthi
Ashok Godavarthi
SBSebastian T. Balcombe
Sebastian T. Balcombe
EVEcaterina Vasenina
Ecaterina Vasenina
Background: Ulva lactuca (sea lettuce) is a green macroalgae rich in sulfated polysaccharides (ulvans), polyphenols, and pigments with documented antioxidant and anti-inflammatory activity in preclinical models. Translational human data remain limited. Methods: Twenty healthy adults (20–35 years; BMI 18.5–30 kg/m2) were enrolled in a single-center, randomized, double-blind, placebo-controlled, parallel-group trial (CTRI/2025/11/097278) and assigned 1:1 to receive 300 mg of an U. lactuca extract or matched placebo once daily for 28 days. Antioxidant biomarkers (GSH, MDA, catalase, GPx-1, thioredoxin) and inflammatory biomarkers (CRP, IL-6, IL-1β, IL-11, PPAR-γ) were measured at Day 0 and Day 28. Safety was assessed throughout. Results: Eighteen of 20 participants completed the study. Compared with placebo, U. lactuca produced significant within-group improvements at Day 28 in GSH (+4.04 ng/mL), GPx-1 (+67.8 µU/mL), and catalase (+32.4 kU/L) and reductions in MDA (−6.08 nmol/mL) and thioredoxin (−1.48 ng/mL); inflammatory markers CRP (−0.91 mg/L), IL-6 (−2.97 pg/mL), IL-11 (−4.28 ± 1.88 ng/mL) and IL-1β (−8.87 pg/mL) decreased and PPAR-γ increased. Conclusions: In this short-duration pilot trial, daily supplementation with 300 mg of an U. lactuca extract was well tolerated and modulated systemic oxidative-stress and low-grade inflammatory biomarkers in healthy adults. Larger and longer studies in populations with elevated oxidative stress are warranted.

22 June 2026 in Applied Physiology, Nutrition, and Metabolism
Verified
Journal Article
Closed access
Carlo RossiCarlo Rossi
Carlo Rossi
KLKworweinski Lafontant
Kworweinski Lafontant
EVEcaterina Vasenina
Ecaterina Vasenina
Jeffrey StoutJeffrey Stout
Jeffrey Stout
David H. FukudaDavid H. Fukuda
David H. Fukuda
Segmental bioelectrical impedance analysis (BIA) evaluates cellular health through phase angle (PhA), resistance (R), and reactance (Xc), providing insights into localized muscle and fluid balance changes during exercise recovery. This exploratory study examined localized bioelectrical impedance analysis (BIA) responses following an eccentric plantar flexor exercise protocol combined with functional testing. Twenty male participants (82.6±16 kg; 177±8.7cm; 23.8±3.45yrs) completed unilateral eccentric plantar flexor resistance training (40% of body mass as a weighted vest, four sets of 50 repetitions, fifth set to failure). One leg was trained (intervention), while the other served as a control. Pre-, immediate post-, and 24-, 48-, and 72-hour post-exercise measurements included segmental intracellular water (ICW), extracellular water (ECW), R, Xc, and PhA at 50kHz, impedance (Z at 5, 50, and 250kHz) and impedance ratio (IR; 250kHz/5kHz). Two-way repeated measures ANOVA revealed significant leg-by-time interactions for all BIA parameters (p0.05), and ECW/ICW which had no significant interaction or main effects. In the intervention leg, R (↓13.9±6.8Ω), IR (↑0.012±0.006), and Xc (↓3.0±1.6Ω) changed immediately post-exercise (p<0.001). PhA decreased immediately post (↓0.31±0.18°) in the intervention leg, increased beyond baseline values at 24hrs (↑0.33±0.20°), and remained elevated at 48hrs (↑0.17±0.27°) compared to pre-testing (p<0.05). Findings demonstrate significant BIA changes in muscles subjected to eccentric exercise, potentially aligned with evidence-based time courses of muscle recovery, which could inform monitoring strategies for training and rehabilitation. OpenScienceFramework Trial Registration ID: 8S2MN.

17 November 2025 in Journal of Dietary Supplements
Verified
Journal Article
Open access
RJRalf Jäger
Ralf Jäger
MPMartin Purpura
Martin Purpura
SBSebastian T. Balcombe
Sebastian T. Balcombe
AGAshok Godavarthi
Ashok Godavarthi
SRSuda A. Reddy
Suda A. Reddy
GTGrant Tinsley
Grant Tinsley
Tart cherry (Prunus cerasus L.) extracts are plant extracts rich in polyphenolic compounds, particularly anthocyanins, which exhibit antioxidant and anti-inflammatory properties. These bioactives may help reduce plasma urate and C-reactive protein (CRP) levels, supporting cardiovascular and the management of hyperuricemia. Processing and formulation methods can influence tart cherry products stability and efficacy. To evaluate the effects of a standardized tart cherry extract on plasma urate and CRP levels. In a randomized, double-blind, placebo-controlled, crossover trial, 10 healthy subjects (n = 10; 6 male, 4 female, age: 34.9 ± 6.6 years, height: 155.3 ± 2.9 cm, weight: 67.1 ± 5.2 kg) consumed 500 mg of a European tart cherry (Prunus cerasus L.) extract powder or placebo for 4 wk, with a 14-day washout between treatment. Venous blood samples were collected at baseline and at 2-, 4-, and 8-h post-ingestion on day 1, as well as at 8 h post-ingestion on day 28, and were analyzed for plasma urate and CRP concentrations. Acute administration did not alter CRP or urate concentrations. Chronic supplementation significantly reduced CRP by 23.0% (- 1.36 ± 0.44 mg/L) and urate by 37.4% (-2.62 ± 0.44 mg/dL) compared to placebo (both p < 0.001). Four weeks of daily supplementation with 500 mg of tart cherry extract significantly reduced systemic inflammation and urate levels in healthy adults, supporting its potential as a polyphenol-rich, foodbased strategy for managing low-grade inflammation and hyperuricemia.

BABrandi Antonio
Brandi Antonio
ESEli S. Shannon
Eli S. Shannon
Darren CandowDarren Candow
Darren Candow
LGLewis Anthony Gough
Lewis Anthony Gough
JGJozo Grgic
Jozo Grgic
JAJose Antonio
Jose Antonio